title: Timed somatic deletion of p53 in mice reveals age-associated differences in tumor progression.
abstract: Inactivating mutations in the p53 tumor suppressor gene occur often in the progression of human cancers. p53 inhibits the outgrowth of nascent cancer cells through anti-proliferative actions (including induction of apoptosis or senescence). To test p53 tumor suppressor functions in a novel experimental context, we somatically deleted both p53 alleles in multiple tissues of mice at various ages. Mice homozygously deleted for p53 at 3 months of age showed a longer tumor latency compared to mice deleted for p53 at 6 and 12 months of age. These results are consistent with a model in which tissues accumulate oncogenically activated cells with age and these are held in check by wildtype p53. We also deleted p53 before, concurrent with, and after treatment of mice with ionizing radiation (IR). The absence or presence of p53 during IR treatment had no effect on radiation-induced lymphoma latency, confirming that the immediate p53 damage response was irrelevant for cancer prevention. Even the presence of wildtype p53 for up to four weeks post-IR provided no protection against early lymphoma incidence, indicating that long term maintenance of functional p53 is critical for preventing the emergence of a cancer. These experiments indicate that sustained p53 anti-oncogenic function acts as a final or near final line of defense preventing progression of oncogenically activated cells to malignant tumors.
authors.affiliation: Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas, USA.
authors.forename: George
authors.initials: G
authors.lastname: Hinkal
authors.forename: Neha
authors.initials: N
authors.lastname: Parikh
authors.forename: Lawrence A
authors.initials: LA
authors.lastname: Donehower
mesh_terms: D000375:Aging / Q000473:pathology*; D000483:Alleles; D000818:Animals; D017209:Apoptosis; D018450:Disease Progression; D017353:Gene Deletion; D016158:Genes, p53; D006720:Homozygote; D008223:Lymphoma / Q000235:genetics / Q000473:pathology*; D051379:Mice; D009381:Neoplasms, Radiation-Induced / Q000235:genetics / Q000473:pathology*; D013629:Tamoxifen / Q000008:administration & dosage
chemical_list: D013629:Tamoxifen
references.citation: Nature. 2006 Sep 14;443(7108):214-7
references.pmid: 16957739
references.citation: Mutagenesis. 1998 Mar;13(2):109-14
references.pmid: 9568581
references.citation: Curr Opin Genet Dev. 2000 Feb;10(1):81-93
references.pmid: 10679386
references.citation: Methods Mol Biol. 2003;234:29-49
references.pmid: 12824523
references.citation: Mutat Res. 2005 Aug 25;576(1-2):4-21
references.pmid: 16038709
references.citation: Physiol Genomics. 2007 Sep 19;31(1):32-41
references.pmid: 17456738
references.citation: Toxicol Pathol. 2001;29 Suppl:147-54
references.pmid: 11695551
references.citation: Nature. 2007 Jul 19;448(7151):375-9
references.pmid: 17637672
references.citation: Nucleic Acids Res. 2003 Feb 15;31(4):e12
references.pmid: 12582257
references.citation: Cell. 1996 Oct 18;87(2):159-70
references.pmid: 8861899
references.citation: Cell. 1997 Feb 7;88(3):323-31
references.pmid: 9039259
references.citation: EMBO J. 2002 Nov 15;21(22):6225-35
references.pmid: 12426394
references.citation: Science. 1996 Mar 22;271(5256):1744-7
references.pmid: 8596939
references.citation: Nat Genet. 1994 Sep;8(1):66-9
references.pmid: 7987394
references.citation: Cancer Cell. 2007 Oct;12(4):303-12
references.pmid: 17936556
references.citation: Genes Dev. 2004 Feb 1;18(3):306-19
references.pmid: 14871929
references.citation: Genes Dev. 1995 Apr 1;9(7):882-95
references.pmid: 7705663
references.citation: Cancer Res. 1995 Sep 1;55(17):3883-9
references.pmid: 7641208
references.citation: Nat Rev Cancer. 2007 Sep;7(9):645-58
references.pmid: 17687385
references.citation: Br J Cancer. 1998;77(2):243-52
references.pmid: 9460995
references.citation: Mutat Res. 2000 Sep 18;452(2):149-62
references.pmid: 11024475
references.citation: Oncogene. 2001 Apr 5;20(15):1803-15
references.pmid: 11313928
references.citation: Curr Opin Genet Dev. 2007 Feb;17(1):66-70
references.pmid: 17208429
references.citation: Genes Dev. 2000 Apr 15;14(8):994-1004
references.pmid: 10783170
references.citation: Oncogene. 1994 Feb;9(2):603-9
references.pmid: 8290271
references.citation: Cell. 2006 Oct 20;127(2):265-75
references.pmid: 17055429
references.citation: Semin Cancer Biol. 1994 Jun;5(3):177-86
references.pmid: 7948946
references.citation: Cell. 2002 Jan 25;108(2):135-44
references.pmid: 11832204
references.citation: Nature. 2002 Jan 3;415(6867):45-53
references.pmid: 11780111
references.citation: Carcinogenesis. 2001 Jun;22(6):839-49
references.pmid: 11375888
references.citation: Proc Natl Acad Sci U S A. 2007 Oct 16;104(42):16633-8
references.pmid: 17921246
references.citation: Oncogene. 1997 Sep;15(11):1295-302
references.pmid: 9315097
references.citation: Trends Cell Biol. 2008 May;18(5):244-52
references.pmid: 18406616
references.citation: Genetics. 2005 Jan;169(1):265-74
references.pmid: 15466429
references.citation: Mech Ageing Dev. 2009 Apr;130(4):262-71
references.pmid: 19396980